IRPALIV Trademark

Trademark Overview


On Sunday, November 12, 2023, a trademark application was filed for IRPALIV with the United States Patent and Trademark Office. The USPTO has given the IRPALIV trademark a serial number of 98266432. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 15, 2024. This trademark is owned by Abbisko Therapeutics Co., Ltd.. The IRPALIV trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, medicinal preparations for the treatment of cancer; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer
irpaliv

General Information


Serial Number98266432
Word MarkIRPALIV
Filing DateSunday, November 12, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, medicinal preparations for the treatment of cancer; Coated capsule anti-tumor medicines for prevention and treatment of human cancer; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbisko Therapeutics Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Party NameAbbisko Therapeutics Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201203
CN

Trademark Events


Event DateEvent Description
Wednesday, June 19, 2024ASSIGNED TO EXAMINER
Thursday, June 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 27, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 15, 2023NEW APPLICATION ENTERED
Thursday, December 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 28, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT